Biotech Showcase
Join us virtually
January 10–12, 2022 &January 17–19, 2022

Harold Bernstein
Chief Medical Officer and SVP at BioMarin

Profile

Dr. Bernstein brings more than three decades of experience in translational medicine and clinical development both in industry and academia. In this role, he will be responsible for fortifying clinical development from early to late stages, working seamlessly with research discovery and overseeing the late stage and life cycle products. Most recently, Dr. Bernstein was Head of Translational Medicine, and Vice President of Global Medicines Development at Vertex. He previously had roles of increasing responsibility at Merck including Head of Cardiometabolic Diseases. He was Professor of Pediatric Cardiology and a senior investigator at the Cardiovascular Research Institute and the Broad Center of Regeneration Medicine at the University of California, San Francisco (UCSF). He also served as attending physician at UCSF Benioff Children's Hospital in Pediatric Cardiology, and in Cardiovascular Genetics. Dr. Bernstein currently holds appointments as attending cardiologist at Mount Sinai Kravis Children's Hospital in New York, as well as Adjunct Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai. He studied biomedical science, human genetics, and medicine at the Mount Sinai School of Medicine, earning an MPhil, PhD, and MD. He completed a pediatric residency, cardiology fellowship, and postdoctoral fellowship at UCSF and earned an undergraduate degree in biological sciences from Harvard University.

Agenda Sessions

  • 2022: A Banner Year for Rare Genetic Disease Therapies?

    08:20